, Singapore

Daily Markets Briefing: STI up 0.78%

Find out who the biggest losers were.

According to KGI Fraser, the sell down in markets was broad based, with US markets declining 6%, oil futures lower by 10% and the STI down by 5%.

In local markets, among the biggest losers declining 5 to 15% for the week were Offshore & Marine stocks (Keppel, Sembcorp Industries, Yangzijiang) and banks (UOB, DBS, OCBC), KGI Fraser said.

Here’s more from KGI Fraser:

We would accumulate high yielding dividend stocks (>7%), notably Croesus Retail Trust ($0.805; BUY TP $0.91), Soilbuild Business Space REIT ($0.755; BUY TP $0.87) and Valuetronics ($0.40; BUY TP $0.67).

Among the banks, OCBC's ($8.4; BUY TP $10.0) 4% dividend yield and trough valuations (i.e. P/B) may offer some support as it trades at its 3 years lows.

In the O&M sector, Triyards' ($0.49; BUY TP $0.55) record order book and revenue visibility for the next two years places it in an excellent positioned to weather the oil market downturn unscathed.
 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare